LAMA / LABA Effect on lung function (SHINE study)
{"Image DocumentName": "LAMA / LABA Effect on lung function (SHINE study)", "Image ImageDescription": "0.08    0.09    0.07    Trough FEV1 at Week 26 (L) Open-label tiotropium 18 \u03bcg qd. Glyco-pyrronium 50 \u03bcg qd. Indacaterol 150 \u03bcg qd. QVA /50 \u03bcg qd. Reference. Bateman ED, Ferguson GT, Barnes N et al. Dual bronchodilation with once-daily QVA149 versus single bronchodilator therapy: the SHINE study. Eur Resp J 2013; In press. Placebo. 0.13    0.12       P<0.001 QVA149, glycopyrronium plus indacaterol. 0.13    0.20    26-week randomized, controlled SHINE study in patients with moderate-to-severe COPD (n=2144) Bateman et al, Eur Resp J 2013 [Epub ahead of print]", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}